Use of neurological criteria to declare death in childrenDEVELOPMENTAL MEDICINE AND CHILD NEUROLOGYIF4.32024-05-081PRE
Hippocampal sclerosis and temporal lobe epilepsy following febrile status epilepticus: The FEBSTAT studyEPILEPSIAIF6.62024-04-123PRE
Fetal anomaly diagnosis and termination of pregnancy胎儿异常诊断与终止妊娠DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGYIF4.32023-02-0216PRE
Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent AAN Position StatementNEUROLOGYIF8.52022-01-2513OA
Ethical Perspectives on Costly Drugs and Health Care AAN Position StatementNEUROLOGYIF8.52021-10-053OA
Use of Social Media in Health Care-Opportunities, Challenges, and Ethical Considerations A Position Statement of the American Academy of NeurologyNEUROLOGYIF8.52021-09-2112OA
Author Response: AAN Position Statement: Ethical Issues in Clinical Research in NeurologyNEUROLOGYIF8.52021-02-230PRE
AAN position statement: The COVID-19 pandemic and the ethical duties of the neurologistNEUROLOGYIF8.52020-07-2817OAAI
Practical Bioethics during the Exceptional Circumstances of a PandemicPEDIATRIC NEUROLOGYIF2.12020-07-0110OAAI
AAN position statement: Ethical issues in clinical research in neurologyNEUROLOGYIF8.52020-04-1413PREAI
SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported IndividualsHUMAN MUTATIONIF3.72019-04-2458OAAI
Brain death, the determination of brain death, and member guidance for brain death accommodation requests: AAN position statementNEUROLOGYIF8.52019-01-2986OAAI
Author response: An interdisciplinary response to contemporary concerns about brain death determinationNEUROLOGYIF8.52018-09-112PREAI
An interdisciplinary response to contemporary concerns about brain death determinationNEUROLOGYIF8.52018-02-2768OAAI